Palermo, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 12.935
NA - Nord America 2.013
AS - Asia 1.348
SA - Sud America 288
AF - Africa 59
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 16.663
Nazione #
IT - Italia 10.445
US - Stati Uniti d'America 1.927
NL - Olanda 661
DE - Germania 644
SG - Singapore 625
CN - Cina 341
SE - Svezia 329
BR - Brasile 232
FR - Francia 208
UA - Ucraina 128
GB - Regno Unito 123
IN - India 82
IE - Irlanda 80
VN - Vietnam 63
CA - Canada 59
CH - Svizzera 57
ID - Indonesia 53
FI - Finlandia 40
RU - Federazione Russa 38
ES - Italia 32
BE - Belgio 31
PL - Polonia 29
JP - Giappone 25
TR - Turchia 23
AR - Argentina 21
HK - Hong Kong 21
BD - Bangladesh 20
MA - Marocco 15
MX - Messico 15
AT - Austria 11
AU - Australia 11
ZA - Sudafrica 11
AL - Albania 10
EC - Ecuador 10
IQ - Iraq 10
IR - Iran 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
KR - Corea 8
AZ - Azerbaigian 7
CL - Cile 7
EG - Egitto 7
PK - Pakistan 7
TH - Thailandia 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
PA - Panama 6
TW - Taiwan 6
EU - Europa 5
IL - Israele 5
LT - Lituania 5
PT - Portogallo 5
VE - Venezuela 5
CI - Costa d'Avorio 4
JO - Giordania 4
NG - Nigeria 4
PE - Perù 4
SM - San Marino 4
BG - Bulgaria 3
BO - Bolivia 3
CO - Colombia 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
CV - Capo Verde 2
DK - Danimarca 2
ET - Etiopia 2
IS - Islanda 2
LK - Sri Lanka 2
MT - Malta 2
MY - Malesia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
IM - Isola di Man 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
Totale 16.657
Città #
Milan 1.035
Rome 781
Chandler 347
Naples 326
Singapore 276
Ashburn 228
Turin 211
Florence 172
Bologna 143
Palermo 135
Bari 115
Catania 94
Genoa 93
Dublin 78
Jacksonville 74
Ann Arbor 73
Beijing 73
Los Angeles 73
Verona 73
San Mateo 69
Wilmington 55
Brescia 54
New York 49
Venice 49
Jakarta 48
Padova 45
Frankfurt am Main 43
Nanjing 43
Parma 40
Bergamo 39
Cagliari 38
Taranto 38
Messina 36
Munich 35
Reggio Emilia 34
Pescara 33
Bremen 32
Dearborn 31
Hefei 31
Perugia 31
Salerno 30
Ho Chi Minh City 29
Livorno 28
Ottawa 28
São Paulo 27
Boston 25
Cattolica 25
Hyderabad 25
Brussels 24
Lucca 24
Nürnberg 24
Redwood City 24
The Dalles 24
Marseille 23
Modena 23
Monza 23
Lawrence 22
Hong Kong 21
Moscow 21
Rimini 21
Woodbridge 21
Novara 20
Trieste 20
Chicago 19
Dallas 18
Houston 18
Falls Church 16
Nanchang 16
Princeton 16
Lancaster 15
Amsterdam 14
Caserta 14
Lecce 14
Seattle 14
Buffalo 13
Santa Clara 13
Tianjin 13
Vicenza 13
Cesano Maderno 12
Hanoi 12
Piacenza 12
Tokyo 12
Trento 12
Lamezia Terme 11
Macerata 11
Mountain View 11
Redmond 11
Rende 11
Udine 11
Zurich 11
Ancona 10
Avellino 10
Belo Horizonte 10
Brooklyn 10
Como 10
Denver 10
Düsseldorf 10
Kraków 10
L’Aquila 10
Montreal 10
Totale 6.288
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.157
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 399
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 295
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 181
Urological complications following inguinal hernioplasty 180
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 170
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 166
Hot topics in urological health economics. A mini review 154
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 147
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 142
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 142
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 139
Therapeutic strategies in penile cancer: state of the art 133
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 132
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 126
Imaging in prostate cancer staging: present role and future perspectives 126
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 125
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 123
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 122
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 121
The occult urothelial cancer 117
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 116
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 114
Focal surgery in testis cancer: current state of the art 112
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 112
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 107
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 106
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 98
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 95
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 93
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 93
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 89
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 89
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 86
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 86
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 85
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 82
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 82
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 76
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 75
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 72
[Sport, infertility and erectile dysfunction] 70
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 63
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment 60
Bladder tumor markers: A review of the literature 57
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 55
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 55
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer 54
Imaging in bladder cancer: Present role and future perspectives 43
Totale 16.722
Categoria #
all - tutte 34.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 29 45 13 36 13 58 28
2021/2022464 38 29 5 38 36 35 15 62 26 37 69 74
2022/20232.159 173 150 88 196 85 180 98 181 228 174 351 255
2023/20244.326 258 336 300 332 323 346 369 399 343 431 438 451
2024/20256.068 471 574 579 527 605 485 507 516 630 414 442 318
2025/20262.201 590 266 304 403 590 48 0 0 0 0 0 0
Totale 16.722